Table 2.

Virtual trial results summary for STAR-2D and STAR-3D

	STAR-2D	STAR-3D
Number of patients	681	681
Hours of control (h)	59,073	59,071
Total BG measurements	31,248	31,858
Workload (measurements per day)	12.7	12.9
Median [IQR] BG (mmol/L)	6.3 [5.7 7.0]	6.2 [5.6 6.9]
% BG in 4.4–6.5 mmol/L	56	61
% BG in 4.4–7.0 mmol/L	72	75
% BG in 4.4–8.0 mmol/L	88	88
% BG in 8.0–10.0 mmol/L	8	7
% BG > 10.0 mmol/L	3	3
% BG < 4.4 mmol/L	2	2
% BG < 4.0 mmol/L	1	1
% BG < 2.2 mmol/L	0.03	0.03
# patients < 2.2 mmol/L	11 (1.6%)	11 (1.6%)
Median [IQR] insulin rate (U/h)	2.5 [1.5 4.5]	3.0 [1.5 5.0]
Median [IQR] dextrose rate (%GF)	95 [40 100]	97 [36 100]